These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2977202)

  • 1. [Functions and structure of complement inactivators in plasma. 2). I factor].
    Hirose S; Kaneko I
    Nihon Rinsho; 1988 Sep; 46(9):1904-9. PubMed ID: 2977202
    [No Abstract]   [Full Text] [Related]  

  • 2. C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.
    Volanakis JE
    Year Immunol; 1989; 4():218-30. PubMed ID: 2648703
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third component of trout complement. cDNA cloning and conservation of functional sites.
    Lambris JD; Lao Z; Pang J; Alsenz J
    J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functions and structure of complement inactivators in membrane proteins. 2). Decay-accelerating factor].
    Sugita Y
    Nihon Rinsho; 1988 Sep; 46(9):1927-32. PubMed ID: 2468004
    [No Abstract]   [Full Text] [Related]  

  • 6. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor H binds to the N-terminus of adiponectin and modulates complement activation.
    Peake P; Shen Y
    Biochem Biophys Res Commun; 2010 Jun; 397(2):361-6. PubMed ID: 20513355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificities of the protease of mouse serum Ra-reactive factor.
    Ogata RT; Low PJ; Kawakami M
    J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
    Strunk RC; Giclas PC
    J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress on complement protein chemistry and the molecular mechanism of activation. Alternative complement pathway].
    Kinoshita T
    Nihon Rinsho; 1988 Sep; 46(9):1894-8. PubMed ID: 3241383
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure and function of alternative pathway components of complement].
    Tomita M; Sugita Y
    Tanpakushitsu Kakusan Koso; 1986 Jul; 31(9 Suppl):847-64. PubMed ID: 3641329
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure and molecular genetics of complement proteins. An update.
    Volanakis JE
    Year Immunol; 1986; 2():164-76. PubMed ID: 3554821
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I; Sorvillo J; Halbwachs-Mecarelli L
    J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human alternative complement pathway: biology and immunopathology of activation and regulation.
    Kazatchkine MD; Nydegger UE
    Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.
    Fries LF; Friedman HM; Cohen GH; Eisenberg RJ; Hammer CH; Frank MM
    J Immunol; 1986 Sep; 137(5):1636-41. PubMed ID: 3018078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase.
    Burge J; Nicholson-Weller A; Austen KF
    J Immunol; 1981 Jan; 126(1):232-5. PubMed ID: 6778916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.